Biomerica Inc Asset Turnover Ratio (BMRA), as of fourth quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biomerica Inc   (NASDAQ: BMRA)
 

Biomerica Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2026, Biomerica Inc 's asset turnover ratio sequentially decreased to 0.51 in the fourth quarter (May 31 2026), this is lower than usual.

Within sector 3 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2026 compared to the preceding quarter from 113 to 1407.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMRA Asset Turnover Ratio (May 31 2026)
IV. Quarter		 (Feb 28 2026)
III. Quarter		 (Nov 30 2025)
II. Quarter		 (Aug 31 2025)
I. Quarter		 (May 31 2025)
IV. Quarter
Y / Y Asset Change 208.11 % -32.35 % -36.41 % -13.19 % -36.41 %
Y / Y Revenue Change 16.96 % -11.8 % -26.04 % -23.63 % -33.01 %
Asset Turnover Ratio (TTM) 0.51 0.75 0.7 0.68 0.71
BMRA's Total Ranking # 1407 # 113 # 1387 # 315 # 1292
Seq. Asset Change 265.09 % -15.61 % -13.59 % 15.73 % -19.84 %
Seq. Revenue Change -11.25 % -18.43 % -12.32 % 84.25 % -33.07 %



Asset Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 4
Healthcare Sector # 183
Overall Market # 1407

Asset Turnover Ratio Statistics
High Average Low
1.41 0.84 0.43
(Aug 31 2022)   (Feb 29 2024)




BMRA Company Profile • Back to BMRA Efficiency Comparisons • Compare BMRA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending May 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending May 31 2026 Assets at quarter ending May 31 2026
Harrow Inc   0.69 $ 274.724  Millions$ 399.729  Millions
Ani Pharmaceuticals Inc  0.68 $ 978.379  Millions$ 1,441.153  Millions
Procept Biorobotics Corporation  0.68 $ 336.764  Millions$ 496.509  Millions
Dentsply Sirona Inc   0.68 $ 3,643.000  Millions$ 5,378.750  Millions
Lantheus Holdings Inc   0.67 $ 1,555.343  Millions$ 2,316.262  Millions
Halozyme Therapeutics Inc   0.67 $ 1,663.738  Millions$ 2,499.171  Millions
Immucell Corporation  0.67 $ 29.777  Millions$ 44.750  Millions
Guardant Health Inc   0.66 $ 1,183.105  Millions$ 1,779.508  Millions
U S Physical Therapy Inc  0.66 $ 812.203  Millions$ 1,222.803  Millions
Resmed Inc   0.66 $ 5,628.170  Millions$ 8,558.245  Millions
Align Technology inc   0.66 $ 4,138.567  Millions$ 6,299.750  Millions
Twist Bioscience Corporation  0.66 $ 431.798  Millions$ 658.093  Millions
Eli Lilly And Company  0.66 $ 79,665.800  Millions$ 121,567.600  Millions
Anika Therapeutics Inc   0.65 $ 121.370  Millions$ 185.642  Millions
Agenus Inc  0.65 $ 132.693  Millions$ 204.959  Millions
Gyre Therapeutics Inc   0.64 $ 119.383  Millions$ 185.104  Millions
Logicmark Inc  0.64 $ 12.544  Millions$ 19.555  Millions
Strata Critical Medical Inc   0.64 $ 211.642  Millions$ 330.217  Millions
Castle Biosciences Inc   0.64 $ 357.278  Millions$ 562.581  Millions
Vericel Corporation  0.63 $ 306.303  Millions$ 482.434  Millions
Bridgebio Pharma Inc   0.63 $ 713.069  Millions$ 1,130.639  Millions
Ss Innovations International Inc  0.63 $ 52.199  Millions$ 82.833  Millions
Zoetis Inc   0.63 $ 9,517.000  Millions$ 15,214.250  Millions
Rigel Pharmaceuticals Inc  0.62 $ 276.785  Millions$ 445.451  Millions
Bioaffinity Technologies Inc   0.62 $ 5.901  Millions$ 9.518  Millions
Macrogenics Inc   0.61 $ 167.674  Millions$ 272.723  Millions
Tg Therapeutics Inc   0.61 $ 799.536  Millions$ 1,314.186  Millions
Heron Therapeutics Inc   0.60 $ 151.507  Millions$ 250.826  Millions
Akebia Therapeutics Inc   0.60 $ 219.060  Millions$ 363.224  Millions
10x Genomics Inc   0.60 $ 616.566  Millions$ 1,028.638  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.